Chemical Formula | (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-carbothioic acid |
Chemical Structure Type | steroid - derived with fluorine, hydroxy, methyl, oxo, propoxy and carbothioic acid groups |
Chemical Formula | (6α,11β,16α,17α)-6,9 - Difluoro - 11 - hydroxy - 16 - methyl - 3 - oxo - 17 - (1 - oxopropoxy)androsta - 1,4 - diene - carbothioic acid |
Molecular Weight | unknown |
Appearance | unknown |
Physical State | unknown |
Melting Point | unknown |
Boiling Point | unknown |
Solubility | unknown |
Density | unknown |
Pka | unknown |
Logp | unknown |
Chemical Formula | (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-carbothioic acid |
Chemical Formula | (6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-carbothioic acid |
Molecular Weight | Calculated value based on atomic weights of elements in formula |
Physical State | Solid/liquid/gas (depending on actual state) |
Melting Point | Value in °C if applicable |
Boiling Point | Value in °C if applicable |
Solubility | Solubility in common solvents like water, ethanol etc. |
Density | Value in g/cm³ |
Appearance | Color, texture etc. |
Pka | Acid dissociation constant value if applicable |
Logp | Octanol - water partition coefficient value |
What is the chemical structure of (6α, 11β, 16α, 17α) -6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) androsteroid-1,4-diene-thiocarboxylic acid
(6α, 11β, 16α, 17α) -6,9-diene-11-hydroxy-16-methyl-3-oxo-17- (1-oxo-propoxy) pregnester- 1,4-diene-ketoacid, this is a complex organic compound. I will describe its chemical structure in the classical Chinese form of "Tiangong Kaiwu".
The structure of this compound is quite exquisite. Its core is the skeleton of the pregnant steroid, which is like the pillar of a building, laying the basic structure. At positions 6 and 9, the structure of the diene is formed, which is like a flexible bridge, connecting different parts. On the 11th position, the hydroxyl group stands proudly, like the tip of a tower, demonstrating its unique activity. The addition of methyl group to the 16th position seems to add a unique decoration to the building, affecting the properties of the whole. The oxo group at the 3rd position is like a strong cornerstone, stabilizing its structure. The 17th position (1-oxo-propoxy) also seems to extend a delicate cantilever, giving the molecule a different function. The 1,4 bis ketenoic acid structure, like the key hub of the building, plays a crucial role in its chemical activity and reaction characteristics.
The various parts of this structure cooperate and influence each other to build this complex and unique chemical structure. The location and properties of each group determine its performance in many aspects such as chemical reactions and biological activities. It is a delicate structure worthy of in-depth investigation in the field of organic chemistry.
What are the pharmacological effects of (6α, 11β, 16α, 17α) -6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) androsteroid-1,4-diene-thiocarboxylic acid
(6α, 11β, 16α, 17α) -6,9-diene-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) pregnesterol-1,4-diene-steroids have a variety of pharmacological effects.
These drugs have anti-inflammatory effects and can effectively reduce the body's inflammatory response. When inflammation occurs, it can inhibit the release and synthesis of inflammatory mediators, such as inhibiting leukocyte chemotaxis, reducing the production of inflammatory factors such as prostaglandins and leukotrienes, thereby relieving inflammatory symptoms such as redness, swelling, heat and pain. It is often used to treat various inflammatory diseases, such as arthritis. It can reduce joint inflammation, swelling and pain, and improve joint function. < Br >
Its immunosuppressive effect is also more significant, which can regulate the immune system and inhibit the activation and proliferation of immune cells. For example, in the field of organ transplantation, it can reduce the body's immune rejection of transplanted organs and improve the survival rate of transplanted organs; for autoimmune diseases, such as systemic lupus erythematosus, it can inhibit the autoimmune system's attack on its own tissues and relieve the progression of the disease.
In addition, this type of drug also has an anti-allergic effect, which can stabilize allergenic cells such as mast cells and prevent the release of allergic mediators such as histamine, thereby reducing the symptoms of allergic reactions. It has a good therapeutic effect on allergic diseases such as allergic rhinitis and urticaria.
What are the applicable conditions of (6α, 11β, 16α, 17α) -6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) androsteroid-1,4-diene-thiocarboxylic acid
(6α, 11β, 16α, 17α) -6,9-diene-11-hydroxy-16-methyl-3-oxo-17- (1-oxo-propoxy) androsteroid-1,4-diene-steroid drugs have specific applicable conditions in the medical field.
This drug can be used for adrenal hypofunction. If the human adrenal cortex is damaged due to autoimmunity, infection and other factors, resulting in insufficient corticosteroid secretion, it will cause a series of symptoms, such as fatigue, loss of appetite, weight loss, etc. This drug can supplement the corresponding hormones and relieve symptoms.
For congenital adrenal hyperplasia, patients have abnormal adrenal cortical hormone synthesis due to defects in certain enzymes. The drug can adjust hormone levels and improve problems such as abnormal sexual characteristics and growth disorders caused by hormone imbalance.
It is also used in autoimmune diseases such as rheumatoid arthritis. In such diseases, the immune system attacks its own tissues, causing joint pain, swelling, and deformities. The drug can reduce inflammation, relieve joint symptoms, and improve patients' quality of life by suppressing the immune response.
In addition, in some severe bronchial asthma attacks, this drug can reduce airway inflammation and edema, relieve bronchospasm, improve ventilation function, and help patients relieve critical symptoms such as breathing difficulties.
When using this type of drug, it is necessary to strictly follow the doctor's advice, because it may bring many adverse reactions. Only reasonable application can protect the health and safety of patients while treating the disease.
What are the adverse reactions of (6α, 11β, 16α, 17α) -6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) androsteroid-1,4-diene-thiocarboxylic acid?
(6α, 11β, 16α, 17α) -6,9-diene-11-hydroxy-16-methyl-3-oxo-17- (1-oxo-propoxy) androsteroid-1,4-diene-steroid compounds The possible adverse reactions may exist, let me say in ancient words.
This compound has an exquisite structure, but it is in the biochemical environment, or there are various disadvantages. It contains specific ethylenically bonded, hydroxy, methyl, oxo and oxygen groups, or leads to various reactions in the body.
First, the ethylenically bonded structure is active, or involves oxidation, addition and other reactions. In the complex biochemical environment in the body, or cause the generation of reactive oxygen species, damage cell components, such as lipid peroxidation, damage cell membranes, and then disturb the normal function of cells. And ethylene bonds or cause immune reactions, resulting in abnormal immune responses in the body, causing inflammation and other discomfort.
Second, although hydroxyl and oxo groups are common structures, they may affect the lipophilic and hydrophilic balance of compounds. Or due to excessive lipophilic, it is easy to accumulate in adipose tissue, difficult to metabolize and excrete, accumulate in the body, or cause accumulation toxicity, involving metabolic organs such as the liver and kidneys.
Third, the introduction of methyl groups, or change the molecular space conformation, affect its binding to targets in vivo. Or cause an increase in non-specific binding. In addition to acting on the intended target, it also binds to other proteins, receptors, etc., causing side effects, such as interfering with normal signal transduction pathways and causing physiological dysfunction.
The structure of the fourth, 17 (1-oxopropoxy), or the active fragment is released due to reactions such as enzymatic hydrolysis. This fragment may cause additional reactions in the body and disrupt biochemical homeostasis.
In summary, this (6α, 11β, 16α, 17α) -6,9-diene-11-hydroxy-16-methyl-3-oxo-17- (1-oxo-propoxy) androsteroid-1,4-diene-steroid compound, although it has specific pharmacological potential, its structural characteristics may lead to many adverse reactions. When developing and applying, it should be carefully investigated.
What is the usage and dosage of (6α, 11β, 16α, 17α) -6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17- (1-oxopropoxy) androsteroid-1,4-diene-thiocarboxylic acid
(Hexaα, undecaβ, hexadecaα, seventeen α) -6,9-diene-11-carbonyl-16-methyl-3-oxo-17- (1-oxo-propoxy) pregnesterol-1,4-diene-steroidal acid, which is a rather complex chemical substance. Its usage and dosage depend on the specific disease, the patient's individual condition and the purpose of treatment.
In the past, doctors used medication according to the patient's symptoms and constitution. If this medicine is used to treat diseases, the patient's pulse, complexion and symptoms may need to be carefully reviewed first. In case of deficiency, the dosage may be lighter to prevent damage; if it is empirical, the dosage may be slightly heavier to achieve the effect of removing evil.
However, this drug is unique in nature, or has certain toxicity and side effects. Therefore, when using the drug, the doctor must carefully weigh the pros and cons. If the dosage is too small, it may not be possible to achieve the expected effect; if the dosage is too much, it is easy to cause adverse reactions, or even endanger the patient's life.
Ancient doctors pay attention to step-by-step medication. When using it for the first time, they often try it in small doses to observe the patient's reaction after taking the drug. If the patient has no discomfort after the drug and the symptoms have improved, then adjust it according to the situation. During the medication period, also pay close attention to the patient's changes, such as diet, sleep, stool, etc., in order to adjust the medication in time. In short, the usage and dosage of (hexaα, undecaβ, hexadecaα, seventeen α) -6,9-diene-11-carbonyl-16-methyl-3-oxo-17- (1-oxo-propoxy) pregnesterol-1,4-diene-steroidal acid need to be carefully considered by professional doctors and carefully used to achieve safe and effective purposes.